Group items tagged

The Royal Pharmaceutical Society (RPS) presented key evidence to the UK COVID-19 Inquiry on 10 September, underscoring the vital role of pharmacists and pharmacy teams during the pandemic. Deirdre Domingo, legal representative for the RPS, delivered the statement during the Module 3 public hearings, which focus on the impact of COVID-19 on healthcare systems across the UK. As the professional body representing pharmacists and pharmaceutical scientists in Great Britain, the RPS urged the Inquiry to consider several critical issues: Recognition of pharmacists as key workers The RPS highlighted the crucial role pharmacy teams played in ensuring continued access to essential medicines and their integral involvement in the roll-out of COVID-19 and flu vaccinations. However, the Society also raised concerns over significant failures and challenges, such as inadequate safety measures to protect pharmacists at work, confusing national guidance, increased hostility towards healthcare professionals, and a disparity in the treatment of community pharmacy compared to NHS staff.

Urethroplasty is a surgical procedure aimed at reconstructing the urethra to address conditions such as urethral strictures. The techniques employed in these surgeries vary based on the stricture's location, underlying cause, and duration.

NHS England announced at the Pharmacy Show this morning that Ministers have decided to amend the Pharmacy First thresholds for the remainder of the year. This decision follows concerns raised by Community Pharmacy England (CPE) regarding difficulties faced by pharmacy owners in meeting the required number of clinical pathway consultations for monthly Pharmacy First payments In response to CPE's representations to the Department of Health and Social Care (DHSC) and NHS England, the threshold was earlier reduced from 20 to 15 in August, and from 30 to 20 in October. At the Pharmacy Show on Monday, Ali Sparke from NHS England announced the revised thresholds, setting them at 20 for November and December 2024. Starting in January and February 2025, the number of clinical pathway consultations needed for the monthly Pharmacy First payment will rise to 25, with a further increase to 30 in March.

With the UK General Election set for 4 July, pharmacy bodies are actively engaging with all political parties to secure support for the community pharmacy sector. They are pressing parties to address urgent issues such as pharmacy closures and medicine shortages. "The upcoming general election is a critical opportunity for us to strengthen supporters of community pharmacy in readiness for the new Parliament," said Janet Morrison, chief executive of Community Pharmacy England (CPE). She stressed the need for unity within the sector in advocating for community pharmacy and raising awareness of the issues with election candidates from all parties. As the general election approaches, CPE has called upon all political parties to support pharmacies by "introducing a long-term sustainable funding model and reviewing the medicines supply chain, including much-needed short-term relief measures."

Trauma can turn our world upside down, leaving scars that are not always visible. Whether it's a car accident, the loss of a loved one, or a natural disaster, serious trauma can deeply affect our mental health. Coping with such events is crucial not only for our immediate well-being but also for our long-term recovery. In this post, we'll explore six psychological tips to help you deal with the aftermath of a traumatic event. By integrating these strategies into your life, you can begin to heal and find a path forward. Keep on reading to learn more! Understanding Trauma What Is Trauma? Trauma is an emotional response to a distressing event or series of events. These events can overwhelm an individual's ability to cope, leading to feelings of helplessness, disorientation, and intense fear. Trauma is not limited to physical injuries; it can deeply affect emotional and mental health. How Trauma Affects the Brain When we experience trauma, our brain goes into survival mode. The amygdala, responsible for detecting threats, becomes overactive. Meanwhile, the prefrontal cortex, which helps with rational thinking, can become underactive. This imbalance can lead to heightened anxiety, flashbacks, and difficulty concentrating.

Pharmacy contractors, particularly those in England and Northern Ireland, faced an extremely challenging 2024. The general election delayed the new Community Pharmacy Contractual Framework (CPCF) negotiations leaving pharmacies in England having to endure further hardship, as a frankly unfit 2019 contract, was effectively extended. We have witnessed pharmacy closures on a weekly basis and it is clear that an increasing number of English contractors are struggling to pay their wholesaler bills on time. It is unacceptable that the Government have allowed this to happen. In Scotland and Wales settlements have factored in inflation, which is essential for the future. Whilst we should be cautiously optimistic about the NHS plan under the new Labour government, I'm acutely aware that the sector urgently needs an injection of cash to help offset the last five years of chronic underfunding. The next English CPCF must be inflation linked, the sector cannot absorb ever-increasing costs. Pharmacy teams already work incredibly hard to deliver care to their patients and communities.

David Thomas, owner of LT Chemists in Newport, will replace Raj Aggarwal OBE as the next National Pharmacy Association (NPA) board member for Wales, following an uncontested election this month. Following the conclusion of a nomination process last week, Baldev Bange, Aisling O'Brien, Sehar Shahid, and Sanjay Ganvir have been re-elected to the Board, representing areas of England and Scotland. Ashley Cohen, Sanjeev Panesar, Sukhi Basra, Salim Jetha, Olivier Picard, and Nick Kaye continue their terms without needing to stand for election this time. They still have another two years to run on their terms as board members. Two board positions remain open. The nomination process is ongoing in Northern Ireland, while in England, five NPA members are contesting the remaining seat, which is open to any member with up to five pharmacies. Hustings for the remaining board position in England will take place shortly and a ballot for this position will take place later this month, according to a statement from NPA.

The 2025/26 pharmacy contract consultation will include a review of the medicine margin and reimbursement arrangements, health and care minister Stephen Kinnock has confirmed. Kinnock made this statement in response to a written question from Nick Timothy, Conservative MP for West Suffolk, who asked the secretary of state for health and social care, if he will review the reimbursement system for pharmacies and GP practices dispensing medicines. Kinnock stated that consultation with Community Pharmacy England (CPE) for the 2025/26 Community Pharmacy Contractual Framework (CPCF) has started and will include "reviewing the allowance for medicine margin as part of funding, and any further changes to the reimbursement arrangements." However, he clarified that there are currently no plans to review the reimbursement system for general practices (GPs) dispensing medicines. Kinnock said: "Dispensing practices receive a dispensing fee, approximately £2.00 to £2.30 per item, which is intended to cover dispensing costs. "This fee is calculated based on forecasted volumes of prescriptions to be dispensed and the size of the funding envelope, according to a methodology agreed by the Department, the General Practitioners Committee (GPC), NHS Employers, and the Welsh Government."

Pharmacy leaders from across the sector need to work together in order to have a stronger voice in the future of the healthcare system, Sir Hugh Taylor, chair of the UK Pharmacy Professional Leadership Advisory Board (UKPPLAB), has told Pharmacy Business. The establishment of this board in April 2024 was the principal recommendation of the UK Commission on Pharmacy Professional Leadership's report, published in February 2023. The report outlined that there is "an urgent need for the pharmacy professions to work collaboratively to deliver on their potential and, together, address a wide range of professional issues". "There's always been a measure of collaboration. And indeed, as we've begun our work, we've begun to unearth more examples of it, which is encouraging. But I think the conclusion that the UK Commission drew was that the fragmented nature of the professional leadership in pharmacy required something more concerted and organised in the form of the board," said Sir Hugh. Setup by the four UK chief pharmaceutical officers, the UKPPLAB is an independent public body, with the aim to enable greater collaboration across the pharmacy professional leadership bodies (PLBs) and specialist professional groups (SPGs), which are its constituent members.